ENHERTU® Reduced the Risk of Disease Progression or Death by 50% vs. Chemotherapy in Patients with HER2 Low Metastatic Breast Cancer with HR Positive and HR Negative DiseaseBusiness Wire • 06/05/22
GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage CancerBusiness Wire • 06/02/22
Cancer treatments may benefit from lessons of pandemic set-backs -AstraZeneca executiveReuters • 05/26/22
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022Business Wire • 05/23/22
If stagflation emerges, buy AstraZeneca and Reckitt, avoid Aviva and BP says analystProactive Investors • 05/18/22
LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferencePRNewsWire • 05/17/22
LogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business UpdatesPRNewsWire • 05/16/22
Proteros Expands Oncology Collaboration and License Agreement with AstraZenecaBusiness Wire • 05/16/22
Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung CancerPRNewsWire • 05/13/22
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual MeetingPRNewsWire • 05/11/22